News
Pharmaceutical giants introduce an insurance-free pathway for top anticoagulant Eliquis, following similar direct-to-patient ...
Bristol Myers and Pfizer said on Thursday they will start selling their blockbuster blood thinner, Eliquis, directly to ...
Drugmakers will offer Eliquis at a 43% discount to uninsured U.S. patients, bypassing insurers and PBMs New $346 monthly ...
Bristol Myers and Pfizer will sell Eliquis directly to U.S. patients at a discounted rate with transparent pricing and ...
The reduced rate will still be almost 10 times the average monthly out-of-pocket costs paid by commercially insured patients.
The joint venture is launching a direct-to-consumer service of Eliquis after discussions with the Trump administration.
Explore more
Taking a page from Eli Lilly and Novo Nordisk, who have launched online programs to sell their diabetes and obesity drugs ...
The direct-to-consumer (DTC) platform – called Eliquis 360 Support – will offer Eliquis (apixaban) to patients who pay for ...
Pfizer, Inc. (NYSE:PFE) is one of the high-margin pharma stocks to buy now. Bristol-Myers Squibb Company (NYSE:BMY) and ...
Many studies have shown that even though these medicines have risks, these risks are much lower than the risk of a stroke ...
Eliquis is a prescription drug used to treat or help prevent certain kinds of blood clots. Discover drug interactions in depth, when to avoid Eliquis, and more.
(Reuters) -US drugmakers Bristol Myers and Pfizer said on Thursday that they will make their blood thinner, Eliquis, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results